GU Cancers 2020 | RCC: challenging clinical scenarios

Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, discusses the challenging clinical scenarios in renal cell carcinoma (RCC). Specifically, Dr Albiges outlines the need for more therapies in the neoadjuvant setting and how clinical trials are addressing this gap investigating axitinib as a possible solution. Additionally, Laurence talks on the use of genomic information to aid therapeutic strategy This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.